VinaR - Repository of the Vinča Nuclear Institute
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   Vinar
  • Vinča
  • Radovi istraživača
  • View Item
  •   Vinar
  • Vinča
  • Radovi istraživača
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Association between vitamin D hypovitaminosis and severe forms of COVID-19

Thumbnail
2023
Main article [PDF] (557.1Kb)
Authors
Ilinčić, Branislava
Tomić Naglić, Dragana
Čabarkapa, Velibor
Bajkin, Ivana
Plećaš Đurić, Aleksandra
Kolarski, Ivor
Bojović, Marko
Urošević, Ivana
Stokić, E.
Isenović, Esma R.
Article (Published version)
Metadata
Show full item record
Abstract
Objective: Hypovitaminosis D may be associated with an increased susceptibility to infection, more severe COVID-19 forms, and a higher risk of death. The objective of this study was to investigate any possible connections between vitamin D status [as measured by serum 25-hydroxyvitamin D (25(OH)D) levels] and COVID-19 severity. Patients and methods: In 2021, a cross-sectional study of consecutive adult COVID-19 patients was conducted. Anthropometric data, comorbidities, hospital setting, length of stay, respiratory support, outcome data, and vitamin D status were all evaluated. Results: The length of hospitalization among participants (n = 74; mean age 57.64 ± 17.83 years, 55.4% male) was 18.58 ± 10 days, the majority of the hospital setting was a medical ward (67.6%), and the respiratory support in the form of mechanical ventilation was represented by 12.2%. Hypertension (54.1%), obesity (64.9%), and overweight (64.9%) were the most common cardiometabolic risk factors. In the study ...group, 44.6% of participants had severe vitamin D deficiency (< 30 nmol/l), while 8.1% had vitamin D insufficiency (50 - 74.9 nmol/l). Furthermore, patients with severe COVID-19 (semi-intensive care unit, intensive care unit) had significantly lower serum 25(OH)D levels (32.9 vs. 20.5 nmol/l; p = 0.007). Participants with severe vitamin D deficiency were older and had more prevalent hypertension, requiring mechanical ventilation; 24.2% experienced a fatal outcome. Conclusions: Severe vitamin D deficiency may contribute significantly to the influence of other cardiometabolic risk factors in COVID-19.

Keywords:
COVID-19 / Vitamin D deficiency / ICU / Cardiovascular risk
Source:
European review for medical and pharmacological sciences, 2023, 27, 11, 5318-5326
Funding / projects:
  • Ministry of Education, Science and Technological Development, Republic of Serbia, Grant no. 200017 (University of Belgrade, Institute of Nuclear Sciences 'Vinča', Belgrade-Vinča) (RS-200017)

DOI: 10.26355/eurrev_202306_32651

ISSN: 1128-3602

WoS: 001047061000022

Scopus: 2-s2.0-85163902384
[ Google Scholar ]
1
URI
https://vinar.vin.bg.ac.rs/handle/123456789/11569
Collections
  • Radovi istraživača
Institution/Community
Vinča
TY  - JOUR
AU  - Ilinčić, Branislava
AU  - Tomić Naglić, Dragana
AU  - Čabarkapa, Velibor
AU  - Bajkin, Ivana
AU  - Plećaš Đurić, Aleksandra
AU  - Kolarski, Ivor
AU  - Bojović, Marko
AU  - Urošević, Ivana
AU  - Stokić, E.
AU  - Isenović, Esma R.
PY  - 2023
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/11569
AB  - Objective: Hypovitaminosis D may be associated with an increased susceptibility to infection, more severe COVID-19 forms, and a higher risk of death. The objective of this study was to investigate any possible connections between vitamin D status [as measured by serum 25-hydroxyvitamin D (25(OH)D) levels] and COVID-19 severity.  Patients and methods: In 2021, a cross-sectional study of consecutive adult COVID-19 patients was conducted. Anthropometric data, comorbidities, hospital setting, length of stay, respiratory support, outcome data, and vitamin D status were all evaluated.  Results: The length of hospitalization among participants (n = 74; mean age 57.64 ± 17.83 years, 55.4% male) was 18.58 ± 10 days, the majority of the hospital setting was a medical ward (67.6%), and the respiratory support in the form of mechanical ventilation was represented by 12.2%. Hypertension (54.1%), obesity (64.9%), and overweight (64.9%) were the most common cardiometabolic risk factors. In the study group, 44.6% of participants had severe vitamin D deficiency (< 30 nmol/l), while 8.1% had vitamin D insufficiency (50 - 74.9 nmol/l). Furthermore, patients with severe COVID-19 (semi-intensive care unit, intensive care unit) had significantly lower serum 25(OH)D levels (32.9 vs. 20.5 nmol/l; p = 0.007). Participants with severe vitamin D deficiency were older and had more prevalent hypertension, requiring mechanical ventilation; 24.2% experienced a fatal outcome.  Conclusions: Severe vitamin D deficiency may contribute significantly to the influence of other cardiometabolic risk factors in COVID-19.
T2  - European review for medical and pharmacological sciences
T1  - Association between vitamin D hypovitaminosis and severe forms of COVID-19
VL  - 27
IS  - 11
SP  - 5318
EP  - 5326
DO  - 10.26355/eurrev_202306_32651
ER  - 
@article{
author = "Ilinčić, Branislava and Tomić Naglić, Dragana and Čabarkapa, Velibor and Bajkin, Ivana and Plećaš Đurić, Aleksandra and Kolarski, Ivor and Bojović, Marko and Urošević, Ivana and Stokić, E. and Isenović, Esma R.",
year = "2023",
abstract = "Objective: Hypovitaminosis D may be associated with an increased susceptibility to infection, more severe COVID-19 forms, and a higher risk of death. The objective of this study was to investigate any possible connections between vitamin D status [as measured by serum 25-hydroxyvitamin D (25(OH)D) levels] and COVID-19 severity.  Patients and methods: In 2021, a cross-sectional study of consecutive adult COVID-19 patients was conducted. Anthropometric data, comorbidities, hospital setting, length of stay, respiratory support, outcome data, and vitamin D status were all evaluated.  Results: The length of hospitalization among participants (n = 74; mean age 57.64 ± 17.83 years, 55.4% male) was 18.58 ± 10 days, the majority of the hospital setting was a medical ward (67.6%), and the respiratory support in the form of mechanical ventilation was represented by 12.2%. Hypertension (54.1%), obesity (64.9%), and overweight (64.9%) were the most common cardiometabolic risk factors. In the study group, 44.6% of participants had severe vitamin D deficiency (< 30 nmol/l), while 8.1% had vitamin D insufficiency (50 - 74.9 nmol/l). Furthermore, patients with severe COVID-19 (semi-intensive care unit, intensive care unit) had significantly lower serum 25(OH)D levels (32.9 vs. 20.5 nmol/l; p = 0.007). Participants with severe vitamin D deficiency were older and had more prevalent hypertension, requiring mechanical ventilation; 24.2% experienced a fatal outcome.  Conclusions: Severe vitamin D deficiency may contribute significantly to the influence of other cardiometabolic risk factors in COVID-19.",
journal = "European review for medical and pharmacological sciences",
title = "Association between vitamin D hypovitaminosis and severe forms of COVID-19",
volume = "27",
number = "11",
pages = "5318-5326",
doi = "10.26355/eurrev_202306_32651"
}
Ilinčić, B., Tomić Naglić, D., Čabarkapa, V., Bajkin, I., Plećaš Đurić, A., Kolarski, I., Bojović, M., Urošević, I., Stokić, E.,& Isenović, E. R.. (2023). Association between vitamin D hypovitaminosis and severe forms of COVID-19. in European review for medical and pharmacological sciences, 27(11), 5318-5326.
https://doi.org/10.26355/eurrev_202306_32651
Ilinčić B, Tomić Naglić D, Čabarkapa V, Bajkin I, Plećaš Đurić A, Kolarski I, Bojović M, Urošević I, Stokić E, Isenović ER. Association between vitamin D hypovitaminosis and severe forms of COVID-19. in European review for medical and pharmacological sciences. 2023;27(11):5318-5326.
doi:10.26355/eurrev_202306_32651 .
Ilinčić, Branislava, Tomić Naglić, Dragana, Čabarkapa, Velibor, Bajkin, Ivana, Plećaš Đurić, Aleksandra, Kolarski, Ivor, Bojović, Marko, Urošević, Ivana, Stokić, E., Isenović, Esma R., "Association between vitamin D hypovitaminosis and severe forms of COVID-19" in European review for medical and pharmacological sciences, 27, no. 11 (2023):5318-5326,
https://doi.org/10.26355/eurrev_202306_32651 . .

DSpace software copyright © 2002-2015  DuraSpace
About the VinaR Repository | Send Feedback

re3dataOpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About the VinaR Repository | Send Feedback

re3dataOpenAIRERCUB